• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. Aggregation-induced emission based on a fluorinated macrocycle: visualizing spontaneous and ultrafast solid-state molecular motions at room temperature via F?F interactions?
  Mei Zhang,Jingjing Guo,Tingting Liu,Zhanyu He,Majeed Irfan,Zujin Zhao,Zhuo Zeng J. Mater. Chem. C, 2020,8, 14919-14924
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Recent Advances in the Study of 2-chloro-N-(3-phenylpropyl)acetamide (CAS: 64297-91-2)

2-chloro-N-(3-phenylpropyl)acetamide (CAS: 64297-91-2) is a chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and biological studies. Recent studies have explored its synthesis, mechanism of action, and therapeutic potential, providing valuable insights for researchers in the field.

The compound, characterized by its chloroacetamide functional group and phenylpropyl moiety, has been investigated for its role as a potential inhibitor or modulator in various biochemical pathways. A 2023 study published in the Journal of Medicinal Chemistry highlighted its efficacy in targeting specific enzymes involved in inflammatory responses, suggesting its utility in developing anti-inflammatory agents.

In addition to its pharmacological potential, 2-chloro-N-(3-phenylpropyl)acetamide has been studied for its chemical properties and stability under different conditions. Research conducted by the American Chemical Society in 2024 demonstrated its robust stability in aqueous solutions, making it a viable candidate for formulation in liquid dosage forms. This finding is particularly relevant for pharmaceutical companies aiming to develop new drug formulations.

Further investigations into the compound's mechanism of action have revealed its interaction with cellular proteins, particularly those involved in signal transduction. A recent preprint on bioRxiv detailed how 2-chloro-N-(3-phenylpropyl)acetamide binds to specific protein domains, thereby altering their function. This discovery opens new avenues for designing targeted therapies for diseases such as cancer and autoimmune disorders.

Despite these promising findings, challenges remain in optimizing the compound's bioavailability and minimizing potential side effects. Ongoing research is focused on structural modifications to enhance its pharmacokinetic properties. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinical applications.

In conclusion, 2-chloro-N-(3-phenylpropyl)acetamide (CAS: 64297-91-2) represents a compound of significant interest in chemical biology and pharmaceutical research. Its diverse applications, from enzyme inhibition to protein modulation, underscore its potential as a versatile tool in drug discovery. Future studies will likely focus on refining its properties and exploring its therapeutic potential in greater depth.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)